Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gliclazide MR efficacy and safety during Ramadan fasting in type 2 diabetes
2006-006754-10Phase 3Completed
- Sponsor
- Servier
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gliclazide in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Servier. Primary endpoint: HbA1c. Started Jan 2007; status: completed.
02
Drugs
gliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-006754-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006754-10.